Power Law company profile

Ascentage Pharma

Biotech & Life Sciences · Rockville, United States · Founded 2009 · IPO 2019 Unicorn

China-based clinical-stage biopharmaceutical company

Valuation

$1.96B

Market cap · May/2026

Revenue

$79M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

6 investors on Ascentage Pharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

BioVenture Capital

Oriza Holdings

YuanMing Capital

Series B+ 3 investors entered at this stage

State Development & Investment Corporation (SDIC)

CCB International

ArrowMark Partners

Global footprint

Where Ascentage Pharma has talent and traffic

AI talent share

1.1% of workforce is AI talent
(2 of 181 staff)

Core AI00%

Other AI21.1%

Non-AI workforce17998.9%

Workforce by country

5 countries with
team presence

🇺🇸 United States56.2%

🇨🇳 China34.4%

🇦🇺 Australia7.5%

🇭🇰 Hong Kong1.1%

🇬🇧 United Kingdom1%

5 countries shown

Web traffic by country

4.1K monthly visits
across markets

🇺🇸 United States82.9%

🇮🇳 India17.1%

Top 2 markets shown

Patent intelligence

$66M patent portfolio · 146 active families

Estimated portfolio value

$66M

3.4% of market cap · comparable to top peer Innocare ($56M)

146 active patent families

Where Ascentage Pharma innovates CarcinosisPharmaceutical drugDiseasePharmaceutical medicineOncology

Where Ascentage Pharma concentrates vs peers

Each axis is a top-10 topic across Ascentage Pharma and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Ascentage Pharma

An AI-synthesized read of the highest-engagement posts about Ascentage Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ascentage Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles